These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 21319452)
1. Triglycerides & omega-3s. Prescription omega-3 fatty acids are now among the hypertriglyceridemia therapies. Park NH Adv NPs PAs; 2010 Dec; 1(4):36-40. PubMed ID: 21319452 [No Abstract] [Full Text] [Related]
2. Omega-3 polyunsaturated fatty acids (Omacor) for hypertriglyceridemia. Med Lett Drugs Ther; 2005 Nov; 47(1221):91. PubMed ID: 16267495 [No Abstract] [Full Text] [Related]
3. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia. McKenney JM; Sica D Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707 [TBL] [Abstract][Full Text] [Related]
4. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia. Rupp H Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408 [TBL] [Abstract][Full Text] [Related]
5. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia. Skulas-Ray AC; West SG; Davidson MH; Kris-Etherton PM Expert Opin Pharmacother; 2008 May; 9(7):1237-48. PubMed ID: 18422480 [TBL] [Abstract][Full Text] [Related]
6. Prescription omega-3-acid ethyl esters for the treatment of very high triglycerides. Sadovsky R; Kris-Etherton P Postgrad Med; 2009 Jul; 121(4):145-53. PubMed ID: 19641280 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Adding Omega-3 Fatty Acids in Statin-treated Patients with Residual Hypertriglyceridemia: ROMANTIC (Rosuvastatin-OMAcor iN residual hyperTrIglyCeridemia), a Randomized, Double-blind, and Placebo-controlled Trial. Kim CH; Han KA; Yu J; Lee SH; Jeon HK; Kim SH; Kim SY; Han KH; Won K; Kim DB; Lee KJ; Min K; Byun DW; Lim SW; Ahn CW; Kim S; Hong YJ; Sung J; Hur SH; Hong SJ; Lim HS; Park IB; Kim IJ; Lee H; Kim HS Clin Ther; 2018 Jan; 40(1):83-94. PubMed ID: 29223557 [TBL] [Abstract][Full Text] [Related]
8. Omacor effects on serum lipids and clinical outcome. Ito MK; Marrs J; Williams C Am J Cardiol; 2007 Jan; 99(1):145. PubMed ID: 17196478 [No Abstract] [Full Text] [Related]
9. Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids. Bays H Am J Cardiol; 2006 Aug; 98(4A):71i-76i. PubMed ID: 16919519 [TBL] [Abstract][Full Text] [Related]